Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials

Matteo Santoni, Alessandro Conti, Ugo De Giorgi, Roberto Iacovelli, Francesco Pantano, Luciano Burattini, Giovanni Muzzonigro, Rossana Berardi, Daniele Santini, Stefano Cascinu
  • International Journal of Cancer, November 2013, Wiley
  • DOI: 10.1002/ijc.28544

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/ijc.28544

The following have contributed to this page: Dr Matteo Santoni